JP2024514101A5 - - Google Patents
Info
- Publication number
- JP2024514101A5 JP2024514101A5 JP2023560806A JP2023560806A JP2024514101A5 JP 2024514101 A5 JP2024514101 A5 JP 2024514101A5 JP 2023560806 A JP2023560806 A JP 2023560806A JP 2023560806 A JP2023560806 A JP 2023560806A JP 2024514101 A5 JP2024514101 A5 JP 2024514101A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163169575P | 2021-04-01 | 2021-04-01 | |
| US63/169,575 | 2021-04-01 | ||
| PCT/US2022/023112 WO2022212879A1 (en) | 2021-04-01 | 2022-04-01 | Il-13ra2 chimeric antigen receptors and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024514101A JP2024514101A (ja) | 2024-03-28 |
| JPWO2022212879A5 JPWO2022212879A5 (https=) | 2025-04-08 |
| JP2024514101A5 true JP2024514101A5 (https=) | 2025-04-08 |
Family
ID=81384926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560806A Pending JP2024514101A (ja) | 2021-04-01 | 2022-04-01 | Ｉｌ－１３ｒａ２キメラ抗原受容体および使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240189351A1 (https=) |
| EP (1) | EP4314069A1 (https=) |
| JP (1) | JP2024514101A (https=) |
| WO (1) | WO2022212879A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4588939A1 (en) * | 2024-01-16 | 2025-07-23 | Universitat de Barcelona | Interleukin-13 receptor subunit alpha-2 (il13ralpha2) targeting moieties for the treatment and prevention of il13ralpha2-positive cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7264592B2 (ja) * | 2015-01-26 | 2023-04-25 | ザ ユニバーシティー オブ シカゴ | ＩＬ１３Ｒα２結合剤及び癌治療におけるその使用 |
| CN108456250B (zh) * | 2017-02-17 | 2025-11-28 | 恺兴生命科技(上海)有限公司 | 靶向il-13ra2的抗体及其应用 |
| CN118147137A (zh) | 2017-05-17 | 2024-06-07 | 西雅图儿童医院（Dba西雅图儿童研究所） | 生成哺乳动物t细胞活化诱导型合成启动子(syn+pro)以改善t细胞疗法 |
| WO2019178078A1 (en) * | 2018-03-14 | 2019-09-19 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Il-13 receptor alpha 2 (il13ra2) chimeric antigen receptor for tumor specific t cell immunotherapy |
| US20220195007A1 (en) * | 2019-04-12 | 2022-06-23 | St. Jude Children's Research Hospital, Inc. | Chimeric antigen receptors with cd20 safety switch |
-
2022
- 2022-04-01 JP JP2023560806A patent/JP2024514101A/ja active Pending
- 2022-04-01 US US18/285,218 patent/US20240189351A1/en active Pending
- 2022-04-01 EP EP22718479.3A patent/EP4314069A1/en active Pending
- 2022-04-01 WO PCT/US2022/023112 patent/WO2022212879A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024514101A5 (https=) | ||
| CL2025003802A1 (es) | Composiciones de fluidos de inmersión con contaminantes. | |
| CL2025003714A1 (es) | Acero de baja aleación. | |
| CL2025002518A1 (es) | Composiciones de lactoferrina purificada y métodos de uso. | |
| BR202022009269U2 (https=) | ||
| BY13172U (https=) | ||
| BY23963C1 (https=) | ||
| CN307050169S (https=) | ||
| CN307048815S (https=) | ||
| CN307048303S (https=) | ||
| CN307046735S (https=) | ||
| CN307046201S (https=) | ||
| CN307045580S (https=) | ||
| CN307045547S (https=) | ||
| CN307045446S (https=) | ||
| CN307045395S (https=) | ||
| CN307044960S (https=) | ||
| CN307044496S (https=) | ||
| BY13166U (https=) | ||
| BY23965C1 (https=) | ||
| BY13167U (https=) | ||
| BY13176U (https=) | ||
| BY13175U (https=) | ||
| BY13174U (https=) | ||
| BY23966C1 (https=) |